Literature DB >> 17260100

Detection of polymorphisms in the promoters of matrix metalloproteinases 2 and 9 genes in breast cancer in South Brazil: preliminary results.

Adriana V Roehe, Ana Paula G Frazzon, Grasiela Agnes, Andrea P Damin, Antonio A Hartman, Marcia S Graudenz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17260100     DOI： 10.1007/s10549-006-9273-1

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  9 in total

1.  MMP9 polymorphisms and breast cancer risk: a report from the Shanghai Breast Cancer Genetics Study.

Authors:  Alicia Beeghly-Fadiel; Wei Lu; Xiao-Ou Shu; Jirong Long; Qiuyin Cai; Yongbin Xiang; Yu-Tang Gao; Wei Zheng
Journal:  Breast Cancer Res Treat       Date:  2010-08-20       Impact factor: 4.872

2.  Update analysis of studies on the MMP-9 -1562 C>T polymorphism and cancer risk.

Authors:  Li-Feng Zhang; Yuan-Yuan Mi; Qiang Cao; Wei Wang; Chao Qin; Jun-Feng Wei; Yao-Jun Zhou; Yong-Fei Li; Min Tang; Wei-Min Liu; Wei Zhang; Jian-Gang Zou
Journal:  Mol Biol Rep       Date:  2011-06-30       Impact factor: 2.316

3.  Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.

Authors:  Dalel Ben Néjima; Yosr Ben Zarkouna; Amor Gammoudi; Mohamed Manai; Hamouda Boussen
Journal:  Tumour Biol       Date:  2015-02-06

4.  Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population.

Authors:  Katarzyna Białkowska; Wojciech Marciniak; Magdalena Muszyńska; Piotr Baszuk; Satish Gupta; Katarzyna Jaworska-Bieniek; Grzegorz Sukiennicki; Katarzyna Durda; Tomasz Gromowski; Marcin Lener; Karolina Prajzendanc; Alicja Łukomska; Cezary Cybulski; Tomasz Huzarski; Jacek Gronwald; Tadeusz Dębniak; Jan Lubiński; Anna Jakubowska
Journal:  Hered Cancer Clin Pract       Date:  2020-07-31       Impact factor: 2.857

5.  Matrix metalloproteinase-2 polymorphisms and breast cancer susceptibility.

Authors:  Alicia Beeghly-Fadiel; Wei Lu; Ji-Rong Long; Xiao-ou Shu; Ying Zheng; Qiuyin Cai; Yu-Tang Gao; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05-19       Impact factor: 4.254

6.  MMP-2 -1306C>T polymorphism in breast cancer: a case-control study in a South European population.

Authors:  Flora Zagouri; Theodoros N Sergentanis; Maria Gazouli; Constantine Dimitrakakis; Alexandra Tsigginou; Irene Papaspyrou; Dimosthenis Chrysikos; Maria Lymperi; George C Zografos; Aris Antsaklis; Meletios-Athanassios Dimopoulos; Christos A Papadimitriou
Journal:  Mol Biol Rep       Date:  2013-05-10       Impact factor: 2.316

7.  Association between four MMP-9 polymorphisms and breast cancer risk: a meta-analysis.

Authors:  Xiaoli Zhang; Guoyin Jin; Jianfeng Li; Linxi Zhang
Journal:  Med Sci Monit       Date:  2015-04-19

Review 8.  Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review.

Authors:  Edyta Wieczorek; Ewa Jablonska; Wojciech Wasowicz; Edyta Reszka
Journal:  Tumour Biol       Date:  2014-10-29

9.  Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study.

Authors:  Martha L Slattery; Esther John; Gabriela Torres-Mejia; Mariana Stern; Abbie Lundgreen; Lisa Hines; Anna Giuliano; Kathy Baumgartner; Jennifer Herrick; Roger K Wolff
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.